Search Results - "Chen, Xiewan"
-
1
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Published in Frontiers in immunology (01-05-2020)“…The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed great threat to human…”
Get full text
Journal Article -
2
Characterization of zinc finger protein 536, a neuroendocrine regulator, using pan-cancer analysis
Published in European journal of medical research (08-05-2024)“…Previous studies suggested that zinc finger protein 536 (ZNF536) was abundant in the central brain and regulated neuronal differentiation. However, the role of…”
Get full text
Journal Article -
3
RNA sequencing identifies lung cancer lineage and facilitates drug repositioning
Published in PeerJ (San Francisco, CA) (24-09-2024)“…Recent breakthrough therapies have improved survival rates in non-small cell lung cancer (NSCLC), but a paradigm for prospective confirmation is still lacking…”
Get full text
Journal Article -
4
A case report: delayed high fever and maculopapules during Sorafenib treatment of ectopic hepatocellular carcinoma
Published in BMC cancer (27-07-2016)“…Sorafenib is the standard first-line therapy for hepatocellular carcinoma (HCC) and probably ectopic hepatocellular carcinoma (EHCC) as well. No report…”
Get full text
Journal Article -
5
Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
Published in Oncology letters (01-06-2019)“…The prognosis of non-small cell lung cancer (NSCLC) is poor, particularly for patients with metastatic disease. Numerous efforts have been made to improve the…”
Get full text
Journal Article -
6
Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population‐based analysis
Published in Thoracic cancer (01-04-2019)“…Background The study was conducted to compare the clinicopathological characteristics, survival outcomes, and metastatic patterns between pulmonary large cell…”
Get full text
Journal Article -
7
Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non-Small-Cell Lung Cancer
Published in Frontiers in molecular biosciences (24-01-2022)“…The intervention timing of immune checkpoint inhibitors (ICIs) and radiotherapy fractionations are critical factors in clinical efficacy. This study aims to…”
Get full text
Journal Article -
8
Programmable dual responsive system reconstructing nerve interaction with small-diameter tissue-engineered vascular grafts and inhibiting intimal hyperplasia in diabetes
Published in Bioactive materials (01-01-2022)“…Small-diameter tissue-engineered vascular grafts (sdTEVGs) with hyperglycemia resistance have not been constructed. The intimal hyperplasia caused by…”
Get full text
Journal Article -
9
Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications
Published in Oncotarget (07-03-2017)“…Local and distant recurrence of malignant tumors following radio- and/or chemotherapy correlates with poor prognosis of patients. Among the reasons for cancer…”
Get full text
Journal Article -
10
Concurrent EGFR‐TKI and Thoracic Radiotherapy as First‐Line Treatment for Stage IV Non‐Small Cell Lung Cancer Harboring EGFR Active Mutations
Published in The oncologist (Dayton, Ohio) (01-08-2019)“…Lessons Learned This single‐arm, phase II study shows that concurrent EGFR‐tyrosine kinase inhibitor plus thoracic radiotherapy as the first‐line treatment for…”
Get full text
Journal Article -
11
Population-based high-dimensional analyses identify multiple intrinsic characters for cancer vaccines against lung squamous cell carcinoma
Published in Medical oncology (Northwood, London, England) (03-01-2024)“…In lung squamous cell carcinoma (LUSC), current cancer vaccines show promising effects, despite a lack of benefit for a large number of patients. We first…”
Get full text
Journal Article -
12
High-resolution transcriptomics analysis of CXCL13 + EPSTI1 + CDK1 + cells with a specific focus on lung adenocarcinoma
Published in Journal of thoracic disease (30-01-2024)“…Programmed cell death ligand 1 (PD-L1) blocking therapy has transformed the treatment of lung adenocarcinoma (LUAD), which has significantly changed the…”
Get full text
Journal Article -
13
Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation
Published in Oncotarget (25-10-2016)“…Acquired resistance is a bottleneck that restricts the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) for lung cancer…”
Get full text
Journal Article -
14
A shift of focus is required in English courses for Chinese medical postgraduates
Published in Medical teacher (01-04-2015)Get full text
Journal Article -
15
In-career medical English training for doctors in China
Published in Medical education (01-11-2012)Get full text
Journal Article -
16
Clinical benefits of Livin peptide-loaded DCs/CIKs combined with chemotherapy in advanced non-small cell lung cancer
Published in American journal of cancer research (01-01-2019)“…Previous studies showed that Livin, a member of inhibitors of apoptosis protein (IAP), played an important role in drug and radiation resistance. When the…”
Get full text
Journal Article -
17
In-career medical English training for doctors in China: really good stuff
Published in Medical education (01-11-2012)Get full text
Journal Article -
18
Developing cross-cultural competence in Chinese medical students
Published in Medical teacher (01-09-2013)Get full text
Journal Article -
19
Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia
Published in Hematology (Luxembourg) (01-07-2013)“…Myelodysplastic syndrome (MDS) is a group of blood-related malignancies caused by disorders of hematopoietic stem cells (HSCs). It is mainly characterized by…”
Get more information
Journal Article